Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Livemint

The board of Ipca Labs has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs Limited and entering into a joint management control agreement with the promoters of Lyka Labs… [+1606 chars] Shares of Ipca Labs were trading 1% lower at ?2037.80 while Lyka were locked in 5% upper circuit as compared to a 0.5% gain in Nifty pharma index. Read More